Changes in Arterial Oxygen Tension Correlate with Changes in End-expiratory Carbon Monoxide Level by Schober, Patrick et al.
CHANGES IN ARTERIAL OXYGEN TENSION
CORRELATE WITH CHANGES IN END-
EXPIRATORY CARBON MONOXIDE LEVEL
Patrick Schober, MD
1, Melanie Kalmanowicz
2,
Lothar A. Schwarte, MD, PhD
1, Joerg Weimann, MD
1
and Stephan A. Loer, MD, PhD, MSc
1
From the
1Department of Anaesthesiology, VU Medisch Centrum,
PO Box 7057, 1007 MB, Amsterdam, The Netherlands.;
2Department of Anaesthesiology, Heinrich-Heine-University,
Moorenstrs, 40225, Du ¨sseldorf, Germany.
Received 16 November 2006. Accepted for publication 11 January
2007.
Address correspondence to P. Schober, Department of Anaesthe-
siology, VU Medisch Centrum, PO Box 7057, 1007 MB,
Amsterdam, The Netherlands.
E-mail: P.Schober@vumc.nl
Schober P, Kalmanowicz M, Schwarte LA, Weimann J, Loer SA.
Changes in arterial oxygen tension correlate with changes in
end-expiratory carbon monoxide level.
J Clin Monit Comput 2007; 21:131–135
ABSTRACT. Objective. Carbon monoxide (CO) and oxygen
compete for haemoglobin binding sites. While the effects of
increased inspiratory oxygen fractions on exhaled carbon
monoxide concentrations have been studied previously, the
relationships between intravascular oxygen tension, blood
carboxyhaemoglobin levels and expiratory CO concentrations
remain unclear. We therefore studied the effects of increases in
arterial oxygen tension as crucial determinant for the
displacement of carbon monoxide from its haemoglobin bond
during lung passage. Methods. Measurements of end-
expiratory CO concentrations (eCO), arterial oxygen tensions
and carboxyhaemoglobin concentrations were performed in 19
patients while breathing air and oxygen. Results. With
increasing PaO2 (from 11.5±1.9 to 35.2±10.3 kPa) end-
expiratory CO concentrations increased from 8.6±4.9 to
16.7±9.4 ppm, p<0.001, with a mean increase of 0.36 ppm
CO per kPa increase in PaO2 (DeCO [ppm] = 0.36
* DPaO2 [kPa]). Increases of arterial oxygen tension correlated
with increases of end-expiratory CO concentration (r
2 = 0.33).
Arterial carboxyhaemoglobin concentrations decreased from
1.06±0.37 during air breathing to 0.92±0.35 % after
5 minutes of oxygen inhalation (p<0.001).
Conclusions. Oxygen-induced increases in exhaled CO
correlate with increases in arterial oxygen tensions.
Furthermore, oxygen inhalation reduces carboxyhaemoglobin
levels, supporting the concept of accelerated CO elimination by
oxygen via the lungs.
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INTRODUCTION
In recent years, endogenous carbon monoxide (CO)
production has been shown to play a critical role during
inﬂammatory processes [1–4]. In line with this, exhaled
CO has been found to be increased in critically ill patients
[5–7], and thus may be used as a diagnostic or monitoring
tool. We and others have previously shown that high
inspired oxygen concentrations, that are often used during
mechanical ventilation in these patients, increase exhaled
CO concentrations [8, 9] and may therefore interfere with
exhaled CO measurements. Since oxygen and CO com-
pete for identical haemoglobin binding sites [10] and this
competition occurs in the vascular rather than the alveolar
compartment, we hypothesize that the oxygen-induced
displacement of CO from haemoglobin largely depends
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sion. Pulmonary capillary oxygen tension is inaccessible to
clinical measurements and arterial oxygen tension (PaO2)
is often used as a surrogate. However, especially in the
critically ill, PaO2 may not be predicted from FiO2 due to
altered gas diffusion through the alveolo-capillary mem-
brane and widely scattered ventilation-perfusion ratios as
part of inﬂammatory pulmonary diseases. Therefore, this
study in 19 patients scheduled for cardiac surgery was
based on the hypothesis that PaO2 rather than the FiO2
may correlate with exhaled CO levels.
METHODS AND MATERIALS
After approval by the Institutional Review Board and
informed consent, patients scheduled for cardiac surgery
(n = 19, Table 1) were routinely instrumented preoper-
atively with arterial lines. Among the patients were two
current smokers who were abstinent for more than
12 hours prior to surgery.
Measurements
End-expiratory CO (eCO in parts per million, ppm)
concentrations were measured with an electrochemical
analyzer (microPac, Dra ¨ger, Lu ¨beck, Germany) with a
sampling rate of 0.5 Hz. According to the manufacturers
speciﬁcations CO is measured in a range from 0 to
400 ppm with a reproducibility of ( 3%). In order to
obtain samples of end-expiratory gas at room air patients
were asked to exhale slowly from total lung capacity to
expiratory reserve volume over a period of approximately
20 seconds into a disposable mouthpiece connected to the
analyzer via a 30 cm hose. At the end of expiration gas
ﬂow ceased and the end-expiratory gas remaining in the
hose (volume 5.9 ml) served as the sample for determi-
nation of alveolar CO concentrations. Technical aspects
of the measurements including time-course and repro-
ducibility have been described in detail previously and we
have shown that a stable alveolar plateau is reached during
expiration [8]. This plateau value was deﬁned as end-
expiratory carbon monoxide concentration.
All measurements were performed in a non-smoking
area (operating theatre). Before each measurement,
ambient CO levels as well as CO concentrations within
the oxygen reservoir were measured to exclude exoge-
nous CO sources.
Arterial oxygen tension (PaO2) and arterial carboxy-
haemoglobin levels (CO-Hb) were measured using a
standard clinical blood gas analyzer (ABL 725, Radiom-
eter, Copenhagen, Denmark).
Study protocol
Baseline measurements of eCO, PaO2, CO-Hb were
performed after patients have been rested for 10 minutes
in a supine position. Subsequently, patients breathed
oxygen via a tightly ﬁtting face mask for 5 minutes until
expiratory oxygen fraction was above 0.9 in all patients
excluding dilution of alveolar gas by residual nitrogen.
Then, all measurements were repeated as described above.
Statistics
Data are presented as mean±standard deviation. Differ-
ences between values obtained during air and oxygen
breathing were analyzed by two-tailed, paired t-test
(Prism 4.0 statistical package, GraphPad Software, San
Diego, CA, USA). Correlations were calculated using
Pearsons correlation coefﬁcient (r
2). A p<0.05 was
considered statistically signiﬁcant.
RESULTS
Oxygen inhalation resulted in an increase in PaO2 from
11.5±1.9 to 35.2±10.3 kPa (p<0.001, Figure 1a), as
well as an increase in eCO levels from 8.6±4.9 to
16.7±9.4 ppm (p<0.001, Figure 1b). As shown in
Figure 2 the increase in PaO2 was associated with an in-
crease in eCO in all patients with exception of one patient
in which eCO levels remained constant. The mean in-
crease in eCO per increase in PaO2 (DeCO/DPaO2) was
0.36±0.28 ppm/kPa with a signiﬁcant correlation be-
tween these two parameters (r
2 = 0.33, p<0.01). More-
over, while eCO increased, arterial carboxyhaemoglobin
concentrations decreased from baseline values of
1.06±0.37 during air breathing to 0.92±0.35 % while
inhalation of oxygen (p<0.001, Figure 3). ECO con-
centrations did not correlate with arterial carboxyhae-
moglobin concentrations (P = 0.83).
Table 1. Demographic data (mean±SD).
Gender (female/male) 3 female/16 male
Age (years) 69.9±7.5
Height (cm) 171.5±8.5
Weight (kg) 83.3±12.7
Baseline haemoglobin (g dl
)1) 12.1±1.3
Baseline arterial PaO2 (kPa) 11.5±1.9
Baseline arterial PaCO2 (kPa) 5.1±0.5
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Exhaled carbon monoxide originates from exogenous
(ambient CO) and endogenous sources. Endogenous CO
production is mainly due to degradation of haeme and the
ﬁrst and rate-limiting step of this metabolic pathway is
catalyzed by microsomal haeme oxygenase [1–3, 11]. Of
the three known isoforms, haeme oxygenase-1 is induc-
ible by oxidative stress and, therefore, elevated exhaled
carbon monoxide levels were suggested to be a non-
invasive marker of local airway and systemic inﬂammation
[5–7, 12–15]. Moreover, elevated expiratory CO con-
centrations may be of diagnostic value in patients with
suspected carbon monoxide intoxication [16]. Since
critically ill patients as well as patients with inﬂammation
or intoxication are often treated with oxygen, awareness
of effects of oxygen inhalation on expiratory and blood
CO concentrations may be helpful in the interpretation of
the obtained measurements.
We measured exhaled carbon monoxide concentrations
in patients in supine position breathing room air or
oxygen. CO concentrations were quantiﬁed with an
electrochemical analyzer as described previously [8]. The
last portions of the exhaled gas represented samples of
alveolar air and were deﬁned as endexpiratory CO
concentrations. All measurements were performed in a
non-smoking area. In addition, we determined CO
concentrations in the ambient air to ensure that all mea-
sured CO represented endogenous carbon monoxide of
the patients. During inhalation of oxygen, we measured
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Fig. 1. Arterial oxygen tensions (PaO2, Figure 1a) and end-expiratory
carbon monoxide concentrations (eCO, Figure 1b) of patients (n = 19,
individual values and mean±SD, * < 0.001) while breathing air (open
circles) and oxygen (closed circles). Open and closed circles representing the
same patient are connected by a line.
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Fig. 2. Arterial oxygen tension (PaO2) and corresponding end-expiratory
carbon monoxide concentration (eCO) of patients (n = 19) while breathing
air (open circles) and oxygen (closed circles). Open and closed circles repre-
senting the same patient are connected by a line. The mean slope corre-
sponding to the mean increase in end-expiratory CO concentration per kPa
increase in PaO2 (DeCO/DPaO2) is 0.36.
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Fig. 3. Arterial carboxyhaemoglobin (CO-Hb) and end-expiratory carbon
monoxide concentration (eCO) of patients (n = 19, mean±SEM) while
breathing air (open circles) and oxygen (closed circles).
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that the alveolar gas was diluted by residual or co-inspired
nitrogen. Endexpiratory oxygen fractions corresponding
to alveolar fractions were above 0.9 in all patients.
It is well established that oxygen competes with CO for
the same haemoglobin binding sites, which is the basis for
treating CO intoxications by inhalation of high oxygen
concentrations. Indeed, we and others have recently
demonstrated that increases in inspiratory oxygen fractions
are associated with an increase in exhaled CO levels [8, 9].
However, this may only be valid for lung regions with a
normal pulmonary gas exchange through the alveolar-
capillary membrane, i.e. a ventilation-to-perfusion ratio
close to 1. Accordingly, ventilation-perfusion mismatch,
as it occurs during lung diseases such as COPD (increased
dead-space ventilation) or the acute respiratory distress
syndrome (increased intrapulmonary shunting), may result
in both impaired oxygen uptake and CO excretion
through the lungs. Therefore, we hypothesized that in-
creases in exhaled CO levels may correlate with increases
in arterial oxygen tensions (PaO2). Indeed, breathing
oxygen through a tightly ﬁtted face mask caused an in-
crease in PaO2 in all patients. On the basis of a wide range
of oxygen-induced changes in PaO2 (3.7 to 42.8 kPa) in
our patients, we found that increases in PaO2 signiﬁcantly
correlated with increases in eCO. Moreover, we dem-
onstrated oxygen inhalation to reduce CO-Hb levels,
supporting the concept of accelerated CO elimination by
oxygen via the lungs. In accordance to our ﬁndings,
Weaver et al. observed in a retrospective analysis in pa-
tients an inverse correlation between arterial oxygen
tension and carboxyhaemoglobin half-life and thus in-
creased elimination [17]. However, Weaver et al. studied
changes in blood CO levels during continuous O2
breathing, not during acute PaO2 changes. Our study
aimed to investigate the relationship between acute
changes in PaO2 and changes in endexpiratory CO con-
centration. To the best of our knowledge, the data show
for the ﬁrst time prospectively a correlation between
DeCO and DPaO2. While our data suggest that eCO
levels obtained in acutely ill patients receiving oxygen
therapy may be erroneously high because of a high PaO2
it must be emphasized that these data only apply to acute
changes of PaO2. However, patients may be treated with
higher inspiratory oxygen concentrations for a longer
period of time and it seems unlikely that acute eCO
changes in this study can reliably represent stable eCO
levels during hours of oxygen therapy. Thus our data may
only serve as a qualitative advisory but do not allow
estimations of PaO2)adjusted eCO concentrations.
Moreover, we did not ﬁnd a correlation between eCO
concentrations and arterial CO-Hb levels, so that CO-Hb
concentrations may not be estimated from eCO
concentrations. Further work is needed to determine the
value of measuring eCO in acutely ill patients, and/or CO
intoxicated patients, and the best procedures for these
clinical scenarios.
In summary, our study demonstrates that
oxygen-induced increases in exhaled CO correlate with
increases in arterial oxygen tensions. This is likely
explained by an accelerated carbon monoxide elimination
during lung passage.
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